首页> 美国卫生研究院文献>Frontiers in Genetics >In silico identification of genetic variants in glucocerebrosidase (GBA) gene involved in Gauchers disease using multiple software tools
【2h】

In silico identification of genetic variants in glucocerebrosidase (GBA) gene involved in Gauchers disease using multiple software tools

机译:使用多种软件工具在计算机上鉴定高雪氏病涉及的葡萄糖脑苷脂酶(GBA)基因的遗传变异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gaucher's disease (GD) is an autosomal recessive disorder caused by the deficiency of glucocerebrosidase, a lysosomal enzyme that catalyses the hydrolysis of the glycolipid glucocerebroside to ceramide and glucose. Polymorphisms in GBA gene have been associated with the development of Gaucher disease. We hypothesize that prediction of SNPs using multiple state of the art software tools will help in increasing the confidence in identification of SNPs involved in GD. Enzyme replacement therapy is the only option for GD. Our goal is to use several state of art SNP algorithms to predict/address harmful SNPs using comparative studies. In this study seven different algorithms (SIFT, MutPred, nsSNP Analyzer, PANTHER, PMUT, PROVEAN, and SNPs&GO) were used to predict the harmful polymorphisms. Among the seven programs, SIFT found 47 nsSNPs as deleterious, MutPred found 46 nsSNPs as harmful. nsSNP Analyzer program found 43 out of 47 nsSNPs are disease causing SNPs whereas PANTHER found 32 out of 47 as highly deleterious, 22 out of 47 are classified as pathological mutations by PMUT, 44 out of 47 were predicted to be deleterious by PROVEAN server, all 47 shows the disease related mutations by SNPs&GO. Twenty two nsSNPs were commonly predicted by all the seven different algorithms. The common 22 targeted mutations are F251L, C342G, W312C, P415R, R463C, D127V, A309V, G46E, G202E, P391L, Y363C, Y205C, W378C, I402T, S366R, F397S, Y418C, P401L, G195E, W184R, R48W, and T43R.
机译:高雪氏病(GD)是由葡萄糖脑苷脂酶缺乏引起的常染色体隐性遗传疾病,葡萄糖脑苷脂酶是一种溶酶体酶,可催化糖脂葡萄糖脑苷脂水解为神经酰胺和葡萄糖。 GBA基因的多态性与高雪氏病的发展有关。我们假设使用多种先进软件工具对SNP进行预测将有助于增加对参与GD的SNP鉴定的信心。酶替代疗法是GD的唯一选择。我们的目标是通过比较研究,使用几种先进的SNP算法来预测/解决有害的SNP。在这项研究中,使用了七个不同的算法(SIFT,MutPred,nsSNP分析仪,PANTHER,PMUT,PROVEAN和SNPs&GO)来预测有害的多态性。在这七个程序中,SIFT发现47 nsSNP有害,MutPred发现46 nsSNP有害。 nsSNP分析仪程序发现47个nsSNP中的43个是引起疾病的SNP,而PANTHER发现47个中的32个具有高度有害性,PMUT将47个中的22个归为病理突变,PROVEAN服务器预测47个中的44个具有有害性,所有图47显示了SNPs&GO的疾病相关突变。七个不同算法共同预测了22个nsSNP。常见的22种靶向突变是F251L,C342G,W312C,P415R,R463C,D127V,A309V,G46E,G202E,P391L,Y363C,Y205C,W378C,I402T,S366R,F397S,Y418C,P401L,G195E,W184R,R48W和T43R 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号